Murai M - Search Results

1

Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells.

Mizuno R, Oya M, Hara S, Matsumoto M, Horiguchi A, Ohigashi T, Marumo K, Murai M. Mizuno R, et al. Among authors: murai m. Oncol Rep. 2005 Sep;14(3):639-44. Oncol Rep. 2005. PMID: 16077967

2

STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.

Horiguchi A, Oya M, Marumo K, Murai M. Horiguchi A, et al. Among authors: murai m. Kidney Int. 2002 Mar;61(3):926-38. doi: 10.1046/j.1523-1755.2002.00206.x. Kidney Int. 2002. PMID: 11849447 Free article.

3

Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma.

Horiguchi A, Oya M, Uchida A, Marumo K, Murai M. Horiguchi A, et al. Among authors: murai m. J Urol. 2003 Feb;169(2):710-3. doi: 10.1097/01.ju.0000038952.59355.b2. J Urol. 2003. PMID: 12544348

4

Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells.

Mizuno R, Oya M, Shiomi T, Marumo K, Okada Y, Murai M. Mizuno R, et al. Among authors: murai m. J Urol. 2004 Aug;172(2):723-7. doi: 10.1097/01.ju.0000124990.37563.00. J Urol. 2004. PMID: 15247770

5

Inhibition of the ubiquitin-proteasome pathway activates stress kinases and induces apoptosis in renal cancer cells.

Ishizawa J, Yoshida S, Oya M, Mizuno R, Shinojima T, Marumo K, Murai M. Ishizawa J, et al. Among authors: murai m. Int J Oncol. 2004 Sep;25(3):697-702. Int J Oncol. 2004. PMID: 15289872

6

Survivin associates with cell proliferation in renal cancer cells: regulation of survivin expression by insulin-like growth factor-1, interferon-gamma and a novel NF-kappaB inhibitor.

Sato A, Oya M, Ito K, Mizuno R, Horiguchi Y, Umezawa K, Hayakawa M, Murai M. Sato A, et al. Among authors: murai m. Int J Oncol. 2006 Apr;28(4):841-6. Int J Oncol. 2006. PMID: 16525632

7

Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor.

Hara S, Oya M, Mizuno R, Horiguchi A, Marumo K, Murai M. Hara S, et al. Among authors: murai m. Ann Oncol. 2005 Jun;16(6):928-33. doi: 10.1093/annonc/mdi182. Epub 2005 Apr 25. Ann Oncol. 2005. PMID: 15851405 Free article.

8

Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.

Kanao K, Mikami S, Mizuno R, Shinojima T, Murai M, Oya M. Kanao K, et al. Among authors: murai m. J Urol. 2008 Sep;180(3):1131-6. doi: 10.1016/j.juro.2008.04.136. Epub 2008 Jul 18. J Urol. 2008. PMID: 18639283

9

Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.

Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M. Horiguchi A, et al. Among authors: murai m. J Urol. 2002 Aug;168(2):762-5. J Urol. 2002. PMID: 12131365

10

Bcl-2 and androgen receptor gene expression in androgen-independent subclone derived from mouse androgen-dependent cells.

Ohigashi T, Ueno M, Nonaka S, Deguchi N, Murai M. Ohigashi T, et al. Among authors: murai m. Cancer Invest. 2002;20(5-6):730-6. doi: 10.1081/cnv-120003542. Cancer Invest. 2002. PMID: 12197229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

790 results

Search Page

Filters